136 related items for PubMed ID: 1739084
1. Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function.
Jindal K, West M, Bear R, Goldstein M.
Am J Kidney Dis; 1992 Jan; 19(1):61-7. PubMed ID: 1739084
[Abstract] [Full Text] [Related]
2. A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis.
West ML, Jindal KK, Bear RA, Goldstein MB.
Kidney Int; 1987 Oct; 32(4):579-84. PubMed ID: 3323596
[Abstract] [Full Text] [Related]
3. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
Knotková V, Nĕmecek K, Tarayeva IE, Krasnova TN.
Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
[Abstract] [Full Text] [Related]
4. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[Abstract] [Full Text] [Related]
5. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
Reichert LJ, Huysmans FT, Assmann K, Koene RA, Wetzels JF.
Ann Intern Med; 1994 Sep 01; 121(5):328-33. PubMed ID: 8042821
[Abstract] [Full Text] [Related]
6. Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone.
Bruns FJ, Adler S, Fraley DS, Segel DP.
Ann Intern Med; 1991 May 01; 114(9):725-30. PubMed ID: 2012353
[Abstract] [Full Text] [Related]
7. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
Clin Nephrol; 1996 Oct 01; 46(4):237-44. PubMed ID: 8905208
[Abstract] [Full Text] [Related]
8. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW, Wetzels JF.
Nephrol Dial Transplant; 2004 Aug 01; 19(8):2036-43. PubMed ID: 15187191
[Abstract] [Full Text] [Related]
9. Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.
Cortazar FB, Leaf DE, Owens CT, Laliberte K, Pendergraft WF, Niles JL.
BMC Nephrol; 2017 Feb 01; 18(1):44. PubMed ID: 28143416
[Abstract] [Full Text] [Related]
10. Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis.
Orlowski T, Rancewicz Z, Lao M, Juskowa J, Klepacka J, Gradowska L, Morzycka-Michalik M, Glyda J.
Klin Wochenschr; 1988 Oct 17; 66(20):1019-23. PubMed ID: 3148785
[Abstract] [Full Text] [Related]
11. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, Minari M, Scalia A, Pedrini L, Pisano G, Grassi C, Farina M, Bellazzi R.
J Am Soc Nephrol; 1998 Mar 17; 9(3):444-50. PubMed ID: 9513907
[Abstract] [Full Text] [Related]
12. Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
Matsumoto Y, Shimada Y, Nojima Y, Moriki T.
Ren Fail; 2013 Aug 17; 35(7):936-41. PubMed ID: 23815417
[Abstract] [Full Text] [Related]
13. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
Liang Q, Li H, Xie X, Qu F, Li X, Chen J.
Ren Fail; 2017 Nov 17; 39(1):512-518. PubMed ID: 28562168
[Abstract] [Full Text] [Related]
14. A 10-year follow-up of idiopathic membranous nephropathy patients on steroids and cyclophosphamide: a case series.
Ram R, Guditi S, Kaligotla Venkata D.
Ren Fail; 2015 Apr 17; 37(3):452-5. PubMed ID: 25594615
[Abstract] [Full Text] [Related]
15. [Immunosuppressive treatment of idiopathic membranous glomerulonephritis with nephrotic syndrome].
Muslimović A, Rasić S, Rebić D, Uncanin S.
Med Arh; 2009 Apr 17; 63(4):187-90. PubMed ID: 20088170
[Abstract] [Full Text] [Related]
16. Cyclophosphamide provides no additional benefit to steroid therapy in the treatment of idiopathic membranous nephropathy.
Alexopoulos E, Sakellariou G, Memmos D, Karamitsos K, Leontsini M, Papadimitriou M.
Am J Kidney Dis; 1993 May 17; 21(5):497-503. PubMed ID: 8488817
[Abstract] [Full Text] [Related]
17. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
Ruggenenti P, Mosconi L, Vendramin G, Moriggi M, Remuzzi A, Sangalli F, Remuzzi G.
Am J Kidney Dis; 2000 Mar 17; 35(3):381-91. PubMed ID: 10692263
[Abstract] [Full Text] [Related]
18. Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis.
Bitencourt Dias C, Pinheiro CC, Malafronte P, Titan S, Alves de Brito G, Gera Abrão J, Dos Santos Silva V, Toledo Barros R, Woronik V.
Clin Nephrol; 2011 Jul 17; 76(1):57-63. PubMed ID: 21722606
[Abstract] [Full Text] [Related]
19. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, D'Amico G.
Am J Kidney Dis; 1997 Sep 17; 30(3):404-12. PubMed ID: 9292570
[Abstract] [Full Text] [Related]
20. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.
Chen M, Li H, Li XY, Lu FM, Ni ZH, Xu FF, Li XW, Chen JH, Wang HY, Chinese Nephropathy Membranous Study Group.
Am J Med Sci; 2010 Mar 17; 339(3):233-8. PubMed ID: 20220333
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
